As a player in the human healthcare sector, HealthActiv has a duty to monitor the safety of the products distributed to patients by collecting and reporting to manufacturers and authorities, where applicable, adverse events that patients may have suffered.
Such monitoring of adverse events is called pharmacovigilance (“PV”). PV requirements exist to allow us, our suppliers, and competent regulatory authorities (such as the Ministry of Health and Wellness in Mauritius and other foreign authorities issuing approvals for product manufacturing) to manage adverse events and to protect public health and ensure the highest standards of quality and the safety of all products marketed locally.
Our PV obligations require us to process personal data of a patient and/or the reporter of an adverse event that we receive to comply with our PV reporting obligations towards manufacturers and relevant regulatory authorities. Hence, we may need to process the following personal data you will provide in the form. Once the complaint is received at our end, it is treated with the utmost confidentiality and a follow up is done.